RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Summary of Reconciliation of Statements of Cash Flows (Detail) - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Jun. 30, 2020 |
Jun. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Cash Flows from Operating Activities: | ||||||||
| Net income (loss) | $ (810,705) | $ (6,725,368) | $ (321,102) | $ 4,595,625 | $ (2,398,841) | $ 5,094,479 | $ (17,665,187) | $ 4,098,520 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
| General and administrative expenses paid by related party | 2,206 | 2,206 | ||||||
| Gain on marketable securities, dividends and interest held in Trust Account | (6,992) | (1,128,747) | (1,114,579) | (1,760,594) | (1,201,382) | (3,322,448) | (1,261,249) | (4,554,158) |
| Gain on revaluation of warrant liability | (5,763,750) | 1,172,500 | (3,617,500) | 2,278,750 | (2,666,250) | 16,533,750 | (520,000) | |
| Changes in operating assets and liabilities: | ||||||||
| Prepaid expenses | (60,016) | 16,903 | (20,595) | 15,654 | (101,988) | 51,905 | (62,738) | |
| Accounts payable | 9,003,790 | 11,337 | (60,517) | (138,629) | 284,630 | 79,620 | 830,344 | 83,995 |
| Accrued expenses | (172,311) | 41,140 | 16,140 | 82,575 | 405,711 | (87,694) | 770,551 | 6,166 |
| Net cash used in operating activities | (367,324) | (97,749) | (328,153) | (836,317) | (615,478) | (1,002,075) | (739,886) | (948,215) |
| Cash Flows from Investing Activities: | ||||||||
| Cash deposited in Trust Account | (287,500,000) | (287,500,000) | (287,500,000) | |||||
| Net cash used in investing activities | (287,500,000) | (287,500,000) | (287,500,000) | |||||
| Cash Flows from Financing Activities: | ||||||||
| Proceeds from note payable to related party | 250,000 | 250,000 | 250,000 | |||||
| Repayment of note payable and advances from related party | (252,206) | (252,206) | (250,000) | |||||
| Proceeds received from initial public offering, gross | 287,500,000 | 287,500,000 | 287,500,000 | |||||
| Proceeds from private placement | 7,750,000 | 7,750,000 | 7,750,000 | |||||
| Offering costs paid | (5,151,990) | (5,151,990) | (5,236,990) | |||||
| Net cash provided by (used in) financing activities | 0 | 0 | 290,095,804 | 290,095,804 | 0 | 290,013,010 | ||
| Net change in cash | (367,324) | (97,749) | (328,153) | 1,759,487 | (615,478) | 1,593,729 | (739,886) | 1,564,795 |
| Cash - beginning of period | 849,909 | 1,589,795 | 1,589,795 | 25,000 | 1,589,795 | 25,000 | 1,589,795 | 25,000 |
| Cash - end of period | 482,585 | 1,492,046 | 1,261,642 | 1,784,487 | 974,317 | 1,618,729 | 849,909 | 1,589,795 |
| Supplemental disclosure of noncash activities: | ||||||||
| Offering costs included in accrued expenses | 85,000 | 85,000 | ||||||
| Offering costs included in accounts payable | 2,600 | 2,600 | 2,600 | |||||
| Change in value of ordinary share subject to possible redemption | 26,789,590 | 26,789,590 | 26,789,590 | |||||
| Deferred underwriting commissions | 9,187,500 | 9,187,500 | 9,187,500 | |||||
| As Reported | ||||||||
| Cash Flows from Operating Activities: | ||||||||
| Net income (loss) | 961,618 | 851,398 | 1,626,364 | (120,091) | 3,076,468 | (1,131,437) | 4,226,759 | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
| General and administrative expenses paid by related party | 2,206 | 2,206 | ||||||
| Gain on marketable securities, dividends and interest held in Trust Account | (1,128,747) | (1,114,579) | (1,760,594) | (1,201,382) | (3,322,448) | (1,261,249) | (4,554,158) | |
| Changes in operating assets and liabilities: | ||||||||
| Prepaid expenses | 16,903 | (20,595) | 15,654 | (101,988) | 51,905 | (62,738) | ||
| Accounts payable | 11,337 | (60,517) | (138,629) | 284,630 | 79,620 | 830,344 | 83,995 | |
| Accrued expenses | 41,140 | 16,140 | 82,575 | 405,711 | (87,694) | 770,551 | 6,166 | |
| Net cash used in operating activities | (97,749) | (328,153) | (188,078) | (615,478) | (353,836) | (739,886) | (299,976) | |
| Cash Flows from Investing Activities: | ||||||||
| Cash deposited in Trust Account | (287,500,000) | (287,500,000) | (287,500,000) | |||||
| Net cash used in investing activities | (287,500,000) | (287,500,000) | (287,500,000) | |||||
| Cash Flows from Financing Activities: | ||||||||
| Proceeds from note payable to related party | 250,000 | 250,000 | 250,000 | |||||
| Repayment of note payable and advances from related party | (252,206) | (252,206) | (250,000) | |||||
| Proceeds received from initial public offering, gross | 287,500,000 | 287,500,000 | 287,500,000 | |||||
| Proceeds from private placement | 7,750,000 | 7,750,000 | 7,750,000 | |||||
| Offering costs paid | (5,800,229) | (5,800,229) | (5,885,229) | |||||
| Net cash provided by (used in) financing activities | 289,447,565 | 289,447,565 | 289,364,771 | |||||
| Net change in cash | (97,749) | (328,153) | 1,759,487 | (615,478) | 1,593,729 | (739,886) | 1,564,795 | |
| Cash - beginning of period | $ 849,909 | 1,589,795 | 1,589,795 | 25,000 | 1,589,795 | 25,000 | 1,589,795 | 25,000 |
| Cash - end of period | 1,492,046 | 1,261,642 | 1,784,487 | 974,317 | 1,618,729 | 849,909 | 1,589,795 | |
| Supplemental disclosure of noncash activities: | ||||||||
| Offering costs included in accrued expenses | 85,000 | 85,000 | ||||||
| Offering costs included in accounts payable | 63,750 | 2,600 | 2,600 | 2,600 | ||||
| Change in value of ordinary share subject to possible redemption | 961,620 | 851,400 | 276,823,340 | (120,090) | 278,273,440 | (1,131,440) | 279,423,730 | |
| Restatement Adjustment | ||||||||
| Cash Flows from Operating Activities: | ||||||||
| Net income (loss) | 5,763,750 | (1,172,500) | 2,969,261 | (2,278,750) | 2,018,011 | (16,533,750) | (128,239) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
| Gain on revaluation of warrant liability | (5,763,750) | 1,172,500 | (3,617,500) | 2,278,750 | (2,666,250) | 16,533,750 | (520,000) | |
| Changes in operating assets and liabilities: | ||||||||
| Net cash used in operating activities | (648,239) | (648,239) | (648,239) | |||||
| Cash Flows from Financing Activities: | ||||||||
| Offering costs paid | 648,239 | 648,239 | 648,239 | |||||
| Net cash provided by (used in) financing activities | 648,239 | 648,239 | 648,239 | |||||
| Supplemental disclosure of noncash activities: | ||||||||
| Offering costs included in accounts payable | (63,750) | |||||||
| Change in value of ordinary share subject to possible redemption | $ (961,620) | $ (851,400) | (250,033,750) | $ 120,090 | (251,483,850) | $ 1,131,440 | (252,634,140) | |
| Deferred underwriting commissions | $ 9,187,500 | $ 9,187,500 | $ 9,187,500 | |||||